Catalyst

Slingshot members are tracking this event:

Tesaro (TSRO) to Enroll Phase 3 PRIMA Trial Evaluating Niraparib in 1L Ovarian Cancer Throughout 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TSRO

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 11, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3, Prima, Niraparib, 1l Ovarian Cancer